Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Sell
39
BCAL Quote, Financials, Valuation and Earnings
Last price:
$14.73
Seasonality move
:
-3.37%
Day range:
$14.70 - $15.34
52-week range:
$12.30 - $18.49
Dividend yield:
0%
P/E ratio:
77.58x
P/S ratio:
2.83x
P/B ratio:
0.93x
Volume:
155.7K
Avg. volume:
113.1K
1-year change:
-0.74%
Market cap:
$475.6M
Revenue:
$127.8M
EPS (TTM):
$0.19
Analysts' Opinion
-
Consensus RatingCalifornia BanCorp has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 1 Buy rating, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $20.00, California BanCorp has an estimated upside of 35.69% from its current price of $14.74.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $19.00 representing 100% downside risk from its current price of $14.74.
Fair Value
-
According to the consensus of 2 analysts, California BanCorp has 35.69% upside to fair value with a price target of $20.00 per share.
BCAL vs. S&P 500
-
Over the past 5 trading days, California BanCorp has underperformed the S&P 500 by -1.71% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
California BanCorp does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
California BanCorp has grown year-over-year revenues for 2 quarters straight. In the most recent quarter California BanCorp reported revenues of $45.5M.
Earnings Growth
-
California BanCorp has grown year-over-year earnings for 1 quarter straight. In the most recent quarter California BanCorp reported earnings per share of $0.51.
Enterprise value:
342.9M
EV / Invested capital:
--
Price / LTM sales:
2.83x
EV / EBIT:
5.27x
EV / Revenue:
2.68x
PEG ratio (5yr expected):
0.05x
EV / Free cash flow:
19.31x
Price / Operating cash flow:
19.02x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
0.18%
Net Income Margin (TTM):
4.25%
Return On Equity:
1.44%
Return On Invested Capital:
1.23%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $92.2M | $97.5M | $127.8M | $22.5M | $45.5M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $0.88 | $1.39 | $0.19 | $0.24 | $0.51 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $275.5M | -- | $199.3M | $216.8M | $530.2M | |
| Total Assets | $1.6B | -- | $2.3B | $2.4B | $4B | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.4B | -- | $2B | $2.1B | $3.5B | |
| Total Equity | $168.9M | -- | $260.4M | $288.2M | $511.8M | |
| Total Debt | $30.3M | -- | $67.8M | $102.9M | $69.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | $50.7M | $18.2M | $11.1M | $18.3M | |
| Cash From Investing | -- | -$83.7M | $395.5M | -$16.5M | $354.5M | |
| Cash From Financing | -- | -$29.1M | $105.6M | -$4.1M | $136.9M | |
| Free Cash Flow | -- | $50.2M | $17.8M | $11.2M | $18.1M | |
BCAL
Sector
Market Cap
$475.6M
$616.2M
Price % of 52-Week High
79.72%
85.86%
Dividend Yield
0%
1.99%
Shareholder Yield
-1.39%
3.77%
1-Year Price Total Return
-0.74%
8.45%
Beta (5-Year)
0.607
0.714
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$14.97
200-day SMA
Sell
Level
$15.19
Bollinger Bands (100)
Sell
Level
15.07 - 17.25
Chaikin Money Flow
Sell
Level
-743K
20-day SMA
Sell
Level
$15.43
Relative Strength Index (RSI14)
Sell
Level
32.39
ADX Line
Buy
Level
20.42
Williams %R
Buy
Level
-97.6401
50-day SMA
Sell
Level
$15.60
MACD (12, 26)
Sell
Level
-0.30
25-day Aroon Oscillator
Sell
Level
-96
On Balance Volume
Sell
Level
-123.3K
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Sell
CA Score
(Annual)
Level (-2.0794)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (4)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
California BanCorp is a registered bank holding company headquartered in San Diego, California. The Bank offers a range of financial products and services to individuals, professionals, and small to medium-sized businesses through its 14 branch offices and four loan production offices serving Northern and Southern California. The Bank’s solutions-driven, relationship-based approach to banking provides accessibility to decision-makers and enhances value through strong partnerships with its clients.
Stock Forecast FAQ
In the current month, BCAL has received 1 Buy ratings 1 Hold ratings, and 0 Sell ratings. The BCAL average analyst price target in the past 3 months is $20.00.
-
Where Will California BanCorp Stock Be In 1 Year?
According to analysts, the consensus estimate is that California BanCorp share price will rise to $20.00 per share over the next 12 months.
-
What Do Analysts Say About California BanCorp?
Analysts are divided on their view about California BanCorp share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that California BanCorp is a Sell and believe this share price will drop from its current level to $19.00.
-
What Is California BanCorp's Price Target?
The price target for California BanCorp over the next 1-year time period is forecast to be $20.00 according to 2 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is BCAL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for California BanCorp is a Leans Bullish. 1 of 2 analysts rates the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of BCAL?
You can purchase shares of California BanCorp via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase California BanCorp shares.
-
What Is The California BanCorp Share Price Today?
California BanCorp was last trading at $14.73 per share. This represents the most recent stock quote for California BanCorp. Yesterday, California BanCorp closed at $14.74 per share.
-
How To Buy California BanCorp Stock Online?
In order to purchase California BanCorp stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
